GRCE·00439U104·US·equity·Healthcare - Biotechnology-13D/G
GRCE (GRACE THERAPEUTICS INC) is held by 17 institutional investors as of Q1 2026. Largest holders: Cerity Partners LLC ($3.9M), BANK OF AMERICA CORP /DE/ ($2.3M), RENAISSANCE TECHNOLOGIES LLC ($1.1M). Net institutional sentiment: Bullish.
See how GRCE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer